B3GNT5 and breast carcinoma: Our data demonstrated that low methylation level in promoter regions of B3GNT5 in breast cancer, especially in BLBC, had a positive correlation with high expression of B3GNT5 through analyzing B3GNT5 methylation datasets and gene expression microarray.